Daniel Glassman (@glassmands) 's Twitter Profile
Daniel Glassman

@glassmands

Consultant Oncoplastic Breast Surgeon | Clinical Lead @MidYorkshireNHS | @spirehealthcare Spire Leeds, Spire Methley Park | Breast surgeon Leeds Wakefield

ID: 3291943359

linkhttps://www.doctify.com/uk/specialist/daniel-glassman calendar_today20-05-2015 21:47:55

412 Tweet

740 Followers

1,1K Following

Annals of Oncology (@annals_oncology) 's Twitter Profile Photo

In Annals of Oncology, the ESMO - Eur. Oncology Clinical Practice Guideline for diagnosis, treatment and follow-up of early breast cancer annalsofoncology.org/article/S0923-… #bcsm

Daniel Glassman (@glassmands) 's Twitter Profile Photo

A recent paper that again shows the benefits of breast conserving surgery and radiotherapy over mastectomy when possible. thebreastonline.com/article/S0960-…

Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

MARCH ISSUE: Prevention of #SeromaFormation and Its Sequelae After #AxillaryLymphNodeDissection: An Up-to-Date Systematic Review and Guideline for Surgeons. #breastcancer rdcu.be/dCliX Society of Surgical Oncology

MARCH ISSUE: Prevention of #SeromaFormation and Its Sequelae After #AxillaryLymphNodeDissection: An Up-to-Date Systematic Review and Guideline for Surgeons. #breastcancer rdcu.be/dCliX <a href="/SocSurgOnc/">Society of Surgical Oncology</a>
Daniel Glassman (@glassmands) 's Twitter Profile Photo

PARTNER trial of neoadjuvant olaparib in triple negative breast cancer, published today which I’m a co-author on. nature.com/articles/s4158…

ASBrS (@asbrs) 's Twitter Profile Photo

It’s time to update our counseling! BCT may have a better survival and has equivalent recurrence to mastectomy. #ASBRS24

It’s time to update our counseling! BCT may have a better survival and has equivalent recurrence to mastectomy. #ASBRS24
OncoAlert (@oncoalert) 's Twitter Profile Photo

NEWS FROM INDUSTRY Results from the DESTINY-Breast06 trial indicate that trastuzumab deruxtecan🧪could become a new standard of care for #HER2 -low 🧬and HER2-ultralow metastatic #BreastCancer patients ➡️showing significant PFS improvements 📈over standard chemotherapy after

NEWS FROM INDUSTRY
Results from the DESTINY-Breast06 trial indicate that trastuzumab deruxtecan🧪could become a new standard of care for #HER2 -low 🧬and HER2-ultralow metastatic #BreastCancer patients

➡️showing significant PFS improvements 📈over standard chemotherapy after
Annals of Oncology (@annals_oncology) 's Twitter Profile Photo

The CDK4/6i abemaciclib has regulatory approval in the metastatic & early settings of HR+/HER2- breast cancer (BC): 🔹Metastatic BC: with an AI as 1st line therapy and with fulvestrant after an AI 🔹Early BC: with endocrine therapy for patients with high risk of recurrence.

BJS Open (@bjsopen) 's Twitter Profile Photo

Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis ➡️doi.org/10.1093/bjsope… This systematic review and meta-analysis of 35 recent observational studies published between 1 January 2000 and

Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis
➡️doi.org/10.1093/bjsope…

This systematic review and meta-analysis of 35 recent observational studies published between 1 January 2000 and
Sameh @ VuMedi (@sameh_vumedi) 's Twitter Profile Photo

Check out Dr. Paolo Tarantino Paolo Tarantino Dana-Farber’s Breast Oncology Center discussing #ASCO24 Breast Cancer highlights focused on top abstracts and clinical practice implications Full📽️on #VuMedi 👇 shorturl.at/Zc79i #bcsm #breastcancer #BestofASCO24

ABS (@absgbi) 's Twitter Profile Photo

📣 New ABS Guidance available 📣 Led by the ABS, a multi-disciplinary writing group has produced new guidance providing #ClinicalTeams with evidence-based recommendations for the management of radial surgical margins after BCS for DCIS. Read here: buff.ly/3BUR9LP

📣 New ABS Guidance available 📣 
Led by the ABS, a multi-disciplinary writing group has produced new guidance providing #ClinicalTeams with evidence-based recommendations for the management of radial surgical margins after BCS for DCIS. Read here: buff.ly/3BUR9LP
Daniel Glassman (@glassmands) 's Twitter Profile Photo

More fantastic reviews by my patients. I see patients with breast symptoms at Spire Methley Park Hospital every Wednesday afternoon. One-stop assessment including consultation, mammograms, ultrasound scans and if needed biopsies all in the same visit. spirehealthcare.com/consultant-pro…

More fantastic reviews by my patients. 
I see patients with breast symptoms at Spire Methley Park Hospital every Wednesday afternoon. One-stop assessment including consultation, mammograms, ultrasound scans and if needed biopsies all in the same visit.
spirehealthcare.com/consultant-pro…